These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Persistent Adherence to Airway Clearance Therapy in Adults With Cystic Fibrosis. Sherman AC, Simonton-Atchley S, Campbell D, Reddy RM, O'Brien CE, Guinee B, Wagner LD, Anderson PJ. Respir Care; 2019 Jul; 64(7):778-785. PubMed ID: 30890632 [Abstract] [Full Text] [Related]
23. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis. Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M, EPIC Study Group. Ann Am Thorac Soc; 2015 Aug; 12(8):1170-6. PubMed ID: 26288390 [Abstract] [Full Text] [Related]
24. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection. Greenwood J, Schwarz C, Sommerwerck U, Nash EF, Tamm M, Cao W, Mastoridis P, Debonnett L, Hamed K. Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995 [Abstract] [Full Text] [Related]
25. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Szczesniak RD, McPhail GL, Duan LL, Macaluso M, Amin RS, Clancy JP. Ann Epidemiol; 2013 Dec; 23(12):771-7. PubMed ID: 24103586 [Abstract] [Full Text] [Related]
26. Accrual of Bone Mass in Children and Adolescents With Cystic Fibrosis. Sharma S, Jaksic M, Fenwick S, Byrnes C, Cundy T. J Clin Endocrinol Metab; 2017 May 01; 102(5):1734-1739. PubMed ID: 28323913 [Abstract] [Full Text] [Related]
27. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related. Koehorst-Ter Huurne K, Kort S, van der Palen J, van Beurden WJ, Movig KL, van der Valk P, Brusse-Keizer M. Int J Chron Obstruct Pulmon Dis; 2016 May 01; 11():1679-88. PubMed ID: 27555758 [Abstract] [Full Text] [Related]
28. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A. JAMA; 1992 Apr 08; 267(14):1947-51. PubMed ID: 1548827 [Abstract] [Full Text] [Related]
29. Body Weight and Body Mass Index in Patients with End-Stage Cystic Fibrosis Stabilize After the Start of Enteral Tube Feeding. Hollander FM, de Roos NM, Belle van Meerkerk G, Teding van Berkhout F, Heijerman HGM, van de Graaf EA. J Acad Nutr Diet; 2017 Nov 08; 117(11):1808-1815. PubMed ID: 28919081 [Abstract] [Full Text] [Related]
30. The relationship between body growth and pulmonary function in children with cystic fibrosis. Woestenenk JW, Stellato RK, Terheggen-Lagro SW, van der Ent CK, Houwen RH. Acta Paediatr; 2014 Feb 08; 103(2):162-7. PubMed ID: 24117796 [Abstract] [Full Text] [Related]
31. Relationship between lung function and Modified Shuttle Test performance in adult patients with cystic fibrosis: a cross-sectional, retrospective study. Doeleman WR, Takken T, Bronsveld I, Hulzebos EH. Physiotherapy; 2016 Jun 08; 102(2):184-8. PubMed ID: 27101722 [Abstract] [Full Text] [Related]
32. Pharmacists' perspectives on monitoring adherence to treatment in Cystic Fibrosis. Mooney K, Ryan C, Downey DG. Int J Clin Pharm; 2016 Apr 08; 38(2):296-302. PubMed ID: 26715548 [Abstract] [Full Text] [Related]
33. Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study. Gao J, Arden M, Hoo ZH, Wildman M. BMC Health Serv Res; 2019 Jun 24; 19(1):420. PubMed ID: 31234848 [Abstract] [Full Text] [Related]
34. Bronchial response to nebulized antibiotics in children with cystic fibrosis. Chua HL, Collis GG, Le Souëf PN. Eur Respir J; 1990 Nov 24; 3(10):1114-6. PubMed ID: 2090472 [Abstract] [Full Text] [Related]
35. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial. Moss RB, Flume PA, Elborn JS, Cooke J, Rowe SM, McColley SA, Rubenstein RC, Higgins M, VX11-770-110 (KONDUCT) Study Group. Lancet Respir Med; 2015 Jul 24; 3(7):524-33. PubMed ID: 26070913 [Abstract] [Full Text] [Related]
36. Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis. De Boeck K, Vermeulen F, Wanyama S, Thomas M, members of the Belgian CF Registry. Eur Respir J; 2011 May 24; 37(5):1091-5. PubMed ID: 21071470 [Abstract] [Full Text] [Related]
37. Adherence to medication in adults with Cystic Fibrosis: An investigation using objective adherence data and the Theoretical Domains Framework. Arden MA, Drabble S, O'Cathain A, Hutchings M, Wildman M. Br J Health Psychol; 2019 May 24; 24(2):357-380. PubMed ID: 30825258 [Abstract] [Full Text] [Related]
38. Adherence to nebulised antibiotics in cystic fibrosis. Latchford G, Duff A, Quinn J, Conway S, Conner M. Patient Educ Couns; 2009 Apr 24; 75(1):141-4. PubMed ID: 18952395 [Abstract] [Full Text] [Related]
39. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJ, O'Dochartaigh C, van Haren EH, Vidal LO, Welte T, Fox HG, Wu J, Charlton B, B-305 Study Investigators. Thorax; 2014 Dec 24; 69(12):1073-9. PubMed ID: 25246664 [Abstract] [Full Text] [Related]
40. Inhaled versus nebulised tobramycin: a real world comparison in adult cystic fibrosis (CF). Harrison MJ, McCarthy M, Fleming C, Hickey C, Shortt C, Eustace JA, Murphy DM, Plant BJ. J Cyst Fibros; 2014 Dec 24; 13(6):692-8. PubMed ID: 24815094 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]